Severe meningococcal infection: a review of epidemiology, diagnosis, and management

Crit Care Clin. 2013 Jul;29(3):393-409. doi: 10.1016/j.ccc.2013.03.001.

Abstract

Neisseria meningitidis, also known as meningococcus, is a relatively uncommon cause of invasive infection, but when it occurs it is frequently severe and potentially life threatening. Meningococcus should be considered and investigated promptly as a potentially etiologic pathogen in any patient with meningitis, or sepsis accompanied by a petechial rash. Suspected patients should receive early appropriate antimicrobial therapy concomitantly with confirmatory invasive diagnostic tests. Vaccines have reduced the incidence of infection with certain non-B meningococcal serogroups, and new serotype B vaccines are on the horizon. This article reviews the epidemiology, diagnosis, and management of severe meningococcal infections.

Keywords: Antimicrobial therapy; Diagnosis; Meningococcal infection; Meningococcus; Neisseria meningitidis; Sepsis.

Publication types

  • Review

MeSH terms

  • APACHE
  • Administration, Intravenous
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / therapeutic use*
  • Bacteremia* / diagnosis
  • Bacteremia* / drug therapy
  • Bacteremia* / epidemiology
  • Bacteremia* / prevention & control
  • Blood Chemical Analysis
  • Brain / diagnostic imaging
  • Cerebrospinal Fluid / chemistry
  • Chemoprevention / methods
  • Chemoprevention / standards
  • Diagnosis, Differential
  • Disease Notification
  • Humans
  • Immunocompromised Host
  • Intensive Care Units
  • Meningitis, Meningococcal / diagnosis
  • Meningitis, Meningococcal / drug therapy
  • Meningitis, Meningococcal / epidemiology
  • Meningitis, Meningococcal / prevention & control
  • Meningococcal Infections* / diagnosis
  • Meningococcal Infections* / drug therapy
  • Meningococcal Infections* / epidemiology
  • Meningococcal Infections* / prevention & control
  • Neisseria meningitidis / drug effects
  • Neisseria meningitidis / isolation & purification
  • Neisseria meningitidis / pathogenicity
  • Prognosis
  • Purpura Fulminans / etiology
  • Purpura Fulminans / microbiology
  • Purpura Fulminans / mortality
  • Risk Assessment / methods
  • Tomography, X-Ray Computed

Substances

  • Anti-Bacterial Agents